Skip to main content

Paradigm Biocapital Advisors LP

SEC CIK
0001855655
Latest filing
Aug 14, 2026

AKRO holding history

Akero Therapeutics, Inc. in every 13F filed by Paradigm Biocapital Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AKRO overviewAll 13F holders of AKROFull Q2 2026 holdings

Shares (Q1 2023)
0
Sold out in Q1 2023
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q3 2022
Holdings of AKRO by Paradigm Biocapital Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20230$00.0%−604,544−100.0%Sold outHolders
Q4 2022604,544$33.1M3.9%−228,721−27.4%ReducedHolders
Q3 2022833,265$28.4M4.0%+833,265NewHolders